CLASS II Device recall · Reported 15 Aug 2012 · FDA Enforcement Report

9NC Coagulation Sodium Citrate recalled by Greiner Bio-One North America

Greiner Bio-One North America is recalling 9NC Coagulation Sodium Citrate 3.2%, distributed nationwide in the US. The recall was initiated on 2 Jul 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #B041206
Quantity recalled838.9 cases (1,006,700 pieces)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2154-2012
FDA event ID
62595
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Terminated
Recall initiated
2 Jul 2012
FDA classified
7 Aug 2012
Reported
15 Aug 2012
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

2 Jul 2012Recall initiated by company
7 Aug 2012Classified by FDA+36 days
15 Aug 2012Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Part of the lot received a lower concentration of citrate solution which may cause falsely lower values for common coagulation tests.

Product as listed by the FDA

3mL 9NC Coagulation Sodium Citrate 3.2%, Item #454334, Greiner Bio-One North America Inc., 4238 Capital Drive, Monroe, NC 28110. Intended Use: Venous blood collection tubes.

Where it was distributed

Nationwide Distribution

Nationwide

Questions about this recall

Why was it recalled?

Part of the lot received a lower concentration of citrate solution which may cause falsely lower values for common coagulation tests.

Which lots are affected?

Lot #B041206

Where was it sold?

Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 17

Other Syringes & Needles recalls

All 1,069